drugset / Trial / NCT00478504
Letrozole Versus Clomifene Citrate for Ovulation Induction
Phase 4
Completed
159 enrolled
University of Nottingham
University Hospitals of Derby and Burton NHS Foundation Trust · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The primary aim of the study is to assess the efficacy of letrozole as an ovulation induction agent and to test the hypothesis that letrozole will generate better pregnancy rates with fewer multiple pregnancies and higher live birth rate than the current standard agent, clomifene citrate in anovular infertile women with polycystic ovarian syndrome.
Timeline
- Start
- 2007-05
- Primary completion
- 2014-06
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clomiphene | Other / unclassified | 100 mg | — |
| Comparator | Letrozole | Other / unclassified | 5 mg | — |